Natera, Inc.
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Stock Options Outstanding by Year
Stock Options Outstanding — Weighted-Average Exercise Price ($/sh) ($)
Natera Stock Options Outstanding: $27.03 in FY2025, down 10.6% from a year earlier.
Latest, FY2025
27.03
Period ended Dec 31, 2025
Change on a year earlier
-10.6%
30.22 in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-Q (2026-08-07) ↗
Reported in Form 10-K/10-Q Note — Stock-Based Compensation (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Stock Options Outstanding — Weighted-Average Exercise Price ($/sh) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 27.03 | -10.6% | Form 10-Q (2026-08-07) ↗ |
| FY2024 | Dec 31, 2024 | 30.22 | +27.8% | Form 10-K (2026-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 23.65 | +12.0% | Form 10-K (2025-02-28) ↗ |
| FY2022 | Dec 31, 2022 | 21.11 | +20.4% | Form 10-K (2024-02-29) ↗ |
| FY2021 | Dec 31, 2021 | 17.54 | +56.7% | Form 10-K (2023-03-01) ↗ |
| FY2020 | Dec 31, 2020 | 11.19 | +7.7% | Form 10-K (2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 10.39 | +35.1% | Form 10-K (2021-02-26) ↗ |
| FY2018 | Dec 31, 2018 | 7.69 | +17.6% | Form 10-K (2020-03-02) ↗ |
| FY2017 | Dec 31, 2017 | 6.54 | – | Form 10-K (2019-03-15) ↗ |
Cite this data
StockData. (2026). Natera Stock Options Outstanding ($), annual FY2017–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/equity-options-outstanding-waep
See every metric in the Natera KPI table. Data updated Nov 2, 2026.